Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-070351
Filing Date
2025-05-13
Accepted
2025-05-13 16:11:17
Documents
74
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rptx-20250331.htm   iXBRL 10-Q 2017724
2 EX-10.1 rptx-ex10_1.htm EX-10.1 44819
3 EX-10.2 rptx-ex10_2.htm EX-10.2 62038
4 EX-10.3 rptx-ex10_3.htm EX-10.3 80255
5 EX-31.1 rptx-ex31_1.htm EX-31.1 17167
6 EX-32.1 rptx-ex32_1.htm EX-32.1 9774
7 GRAPHIC img195062861_0.jpg GRAPHIC 208391
  Complete submission text file 0000950170-25-070351.txt   9558630

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rptx-20250331.xsd EX-101.SCH 1088090
77 EXTRACTED XBRL INSTANCE DOCUMENT rptx-20250331_htm.xml XML 1838470
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39335 | Film No.: 25940198
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)